SBC / revenue moved 266 bp higher
SBC / revenue changed +266 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
SBC / revenue changed +266 basis points from the comparable as-filed period.
Net debt changed -101.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Free-cash-flow proxy changed -216.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Inventory / revenue changed +3891 basis points from the comparable as-filed period.
Operating income changed -103.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Debt / revenue changed -52228 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed -2833 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow changed -194.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Free-cash-flow margin changed -2805 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital changed -14.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Capital expenditure changed -84.1% from the comparable as-filed period.
Working capital / assets changed +1584 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Receivables / revenue changed +2040 basis points from the comparable as-filed period.
R&D / revenue changed +309 basis points from the comparable as-filed period.
Shares outstanding changed +4.1% from the comparable as-filed period. The change ranks at the 75th percentile of 8 prior comparable changes.
Current ratio changed +18.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Capex / revenue changed -28 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Stockholders' equity changed +202.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Stock-based compensation changed +16.5% from the comparable as-filed period.
Operating cash flow / net income changed -110.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Current long-term debt changed +0.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.